Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities 4 min read People and Community Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities AETOSWire May 11, 2023 SALT LAKE CITY and TORONTO and MONTRÉAL — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding...Read More